Mitofusins as determinants of the resistance of glioblastoma multiforme cells to doxorubicin
2021/41/N/NZ3/02823
Keywords
Descriptors
- NZ3_001: Biologia komórki
- NZ3_002: Fizjologia komórki
Panel
NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 20 – announced on 2021-03-15
- Amount awarded
- 207 101 PLN
- Project start date
- 2022-01-13
- Project end date
- 2026-01-12
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Metabolic reprogramming of poly(morpho)nuclear giant cells determines glioblastoma recovery from doxorubicin-induced stress
- Authors:
- Maciej Pudełek, Damian Ryszawy, Katarzyna Piwowarczyk, Sławomir Lasota, Zbigniew Madeja, Sylwia Kędracka-Krok, Jarosław Czyż
- Academic press:
- Journal of Translational Medicine (year: 2024, volume: 22, pages: nie dotyczy), Publisher: BMC, Springer Nature
- Status:
- Published
- DOI:
- 10.1186/s12967-024-05541-9 – link to the publication